BCG vaccine's waning efficacy sustains TB burden; eradication remains elusive

The BCG vaccine, developed over a century ago, provides only partial and waning protection against tuberculosis, primarily in children, leaving adults vulnerable. This persistent limitation explains why TB remains a leading infectious killer despite vaccination efforts. The report underscores the need for new vaccines and improved control strategies.